Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine (Q45372298)
Jump to navigation
Jump to search
scientific article published on May 23, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine |
scientific article published on May 23, 2010 |
Statements
1 reference
Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine (English)
1 reference
Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine (English)
1 reference
Michel Deschuyteneer
1 reference
Abdelatif Elouahabi
1 reference
Dominique Plainchamp
1 reference
Michel Plisnier
1 reference
Dominique Soete
1 reference
Yvon Corazza
1 reference
Laurence Lockman
1 reference
Sandra Giannini
1 reference
Marguerite Deschamps
1 reference
23 May 2010
1 reference
1 reference
6
1 reference
5
1 reference
407-419
1 reference
Identifiers
1 reference
1 reference